Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

906 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The development of psychosomatic and Liaison Psychiatry units in Spain: A national enquiry.
Lobo A, Rabanaque I, Blanch J, Campos R, Ezquiaga E, Farré JM, Gómez-Reino I, Marco C, Navío M, Ochoa E, Parramón G, Ventura T, Aguilar EJ, Artal J, Cuesta M, Devolx VM, Espárrago G, Franco MA, Hernández Fleta JL, Martínez Jambrina JJ, Ortega MÁ, Palomo J, Pérez Costillas L, Roca M. Lobo A, et al. Among authors: cuesta m. J Psychosom Res. 2019 Oct;125:109784. doi: 10.1016/j.jpsychores.2019.109784. Epub 2019 Jul 26. J Psychosom Res. 2019. PMID: 31421327 No abstract available.
A Pharmacovigilance Study in First Episode of Psychosis: Psychopharmacological Interventions and Safety Profiles in the PEPs Project.
Bioque M, Llerena A, Cabrera B, Mezquida G, Lobo A, González-Pinto A, Díaz-Caneja CM, Corripio I, Aguilar EJ, Bulbena A, Castro-Fornieles J, Vieta E, Lafuente A, Mas S, Parellada M, Saiz-Ruiz J, Cuesta MJ, Bernardo M; PEPs GROUP. Bioque M, et al. Among authors: cuesta mj. Int J Neuropsychopharmacol. 2016 Mar 31;19(4):pyv121. doi: 10.1093/ijnp/pyv121. Print 2016 Apr. Int J Neuropsychopharmacol. 2016. PMID: 26506856 Free PMC article.
The network structure of cognitive deficits in first episode psychosis patients.
Sánchez-Torres AM, Peralta V, Gil-Berrozpe GJ, Mezquida G, Ribeiro M, Molina-García M, Amoretti S, Lobo A, González-Pinto A, Merchán-Naranjo J, Corripio I, Vieta E, de la Serna E, Bergé D, Bernardo M, Cuesta MJ; PEPs Group. Sánchez-Torres AM, et al. Among authors: cuesta mj. Schizophr Res. 2022 Jun;244:46-54. doi: 10.1016/j.schres.2022.05.005. Epub 2022 May 17. Schizophr Res. 2022. PMID: 35594732
Spanish version of the Screen for Cognitive Impairment in Psychiatry (SCIP-S): psychometric properties of a brief scale for cognitive evaluation in schizophrenia.
Pino O, Guilera G, Rojo JE, Gómez-Benito J, Bernardo M, Crespo-Facorro B, Cuesta MJ, Franco M, Martinez-Aran A, Segarra N, Tabarés-Seisdedos R, Vieta E, Purdon SE, Díez T, Rejas J; Spanish Working Group in Cognitive Function. Pino O, et al. Among authors: cuesta mj. Schizophr Res. 2008 Feb;99(1-3):139-48. doi: 10.1016/j.schres.2007.09.012. Epub 2007 Oct 23. Schizophr Res. 2008. PMID: 17959358
Neurocognitive diagnosis and cut-off scores of the Screen for Cognitive Impairment in Psychiatry (SCIP-S).
Rojo E, Pino O, Guilera G, Gómez-Benito J, Purdon SE, Crespo-Facorro B, Cuesta MJ, Franco M, Martínez-Arán A, Segarra N, Tabarés-Seisdedos R, Vieta E, Bernardo M, Mesa F, Rejas J; Spanish Working Group in Cognitive Function. Rojo E, et al. Among authors: cuesta mj. Schizophr Res. 2010 Feb;116(2-3):243-51. doi: 10.1016/j.schres.2009.08.005. Epub 2009 Sep 9. Schizophr Res. 2010. PMID: 19744832
Brief cognitive assessment instruments in schizophrenia and bipolar patients, and healthy control subjects: a comparison study between the Brief Cognitive Assessment Tool for Schizophrenia (B-CATS) and the Screen for Cognitive Impairment in Psychiatry (SCIP).
Cuesta MJ, Pino O, Guilera G, Rojo JE, Gómez-Benito J, Purdon SE, Franco M, Martínez-Arán A, Segarra N, Tabarés-Seisdedos R, Vieta E, Bernardo M, Crespo-Facorro B, Mesa F, Rejas J. Cuesta MJ, et al. Schizophr Res. 2011 Aug;130(1-3):137-42. doi: 10.1016/j.schres.2011.05.020. Epub 2011 Jun 11. Schizophr Res. 2011. PMID: 21652178
Utility of the World Health Organization Disability Assessment Schedule II in schizophrenia.
Guilera G, Gómez-Benito J, Pino O, Rojo JE, Cuesta MJ, Martínez-Arán A, Safont G, Tabarés-Seisdedos R, Vieta E, Bernardo M, Crespo-Facorro B, Franco M, Rejas J. Guilera G, et al. Among authors: cuesta mj. Schizophr Res. 2012 Jul;138(2-3):240-7. doi: 10.1016/j.schres.2012.03.031. Epub 2012 Apr 20. Schizophr Res. 2012. PMID: 22521724
Premorbid adjustment and clinical correlates of cognitive impairment in first-episode psychosis. The PEPsCog Study.
Cuesta MJ, Sánchez-Torres AM, Cabrera B, Bioque M, Merchán-Naranjo J, Corripio I, González-Pinto A, Lobo A, Bombín I, de la Serna E, Sanjuan J, Parellada M, Saiz-Ruiz J, Bernardo M; PEPs Group. Cuesta MJ, et al. Schizophr Res. 2015 May;164(1-3):65-73. doi: 10.1016/j.schres.2015.02.022. Epub 2015 Mar 26. Schizophr Res. 2015. PMID: 25819935
Age at First Episode Modulates Diagnosis-Related Structural Brain Abnormalities in Psychosis.
Pina-Camacho L, Del Rey-Mejías Á, Janssen J, Bioque M, González-Pinto A, Arango C, Lobo A, Sarró S, Desco M, Sanjuan J, Lacalle-Aurioles M, Cuesta MJ, Saiz-Ruiz J, Bernardo M, Parellada M; PEPs Group. Pina-Camacho L, et al. Among authors: cuesta mj. Schizophr Bull. 2016 Mar;42(2):344-57. doi: 10.1093/schbul/sbv128. Epub 2015 Sep 14. Schizophr Bull. 2016. PMID: 26371339 Free PMC article.
Pharmacogenetic study of antipsychotic induced acute extrapyramidal symptoms in a first episode psychosis cohort: role of dopamine, serotonin and glutamate candidate genes.
Mas S, Gassó P, Lafuente A, Bioque M, Lobo A, Gonzàlez-Pinto A, Olmeda MS, Corripio I, Llerena A, Cabrera B, Saiz-Ruiz J, Bernardo M; PEPs GROUP. Mas S, et al. Pharmacogenomics J. 2016 Oct;16(5):439-45. doi: 10.1038/tpj.2016.44. Epub 2016 Jun 7. Pharmacogenomics J. 2016. PMID: 27272046
906 results